HALOPERIDOL DECANOATE - Generic Drug Details

✉ Email this page to a colleague

What are the generic drug sources for haloperidol decanoate and what is the scope of patent protection?

Haloperidol decanoate is the generic ingredient in two branded drugs marketed by Janssen Pharms, Fresenius Kabi Usa, Gland Pharma Ltd, Hikma, Hospira, Mankind Pharma, Meitheal, Mylan Labs Ltd, Sandoz, Somerset Theraps Llc, Teva Pharms Usa, and Zydus Pharms, and is included in thirteen NDAs. Additional information is available in the individual branded drug profile pages.

There are five drug master file entries for haloperidol decanoate. Fifteen suppliers are listed for this compound.

Sponsor	Phase
Case Western Reserve University	Phase 3
National Institutes of Health (NIH)	Phase 3
National Institute of Mental Health (NIMH)	Phase 3

Sponsor

Phase

Case Western Reserve University

Phase 3

National Institutes of Health (NIH)

Phase 3

National Institute of Mental Health (NIMH)

Phase 3

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Meitheal	HALOPERIDOL DECANOATE	haloperidol decanoate	INJECTABLE;INJECTION	214507-002	Jul 26, 2021	AO	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Mylan Labs Ltd	HALOPERIDOL DECANOATE	haloperidol decanoate	INJECTABLE;INJECTION	075440-002	Feb 28, 2000	AO	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Zydus Pharms	HALOPERIDOL DECANOATE	haloperidol decanoate	INJECTABLE;INJECTION	211180-001	Oct 22, 2019	AO	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Hospira	HALOPERIDOL DECANOATE	haloperidol decanoate	INJECTABLE;INJECTION	075176-001	Feb 9, 2000		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Mankind Pharma	HALOPERIDOL DECANOATE	haloperidol decanoate	INJECTABLE;INJECTION	216730-001	May 23, 2023	AO	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Meitheal	HALOPERIDOL DECANOATE	haloperidol decanoate	INJECTABLE;INJECTION	214507-001	Jul 26, 2021	AO	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

US Patents:	0
Tradenames:	2
Applicants:	12
NDAs:	13
Drug Master File Entries:	5
Finished Product Suppliers / Packagers:	15
Raw Ingredient (Bulk) Api Vendors:	49
Clinical Trials:	8
Patent Applications:	339
Drug Prices:	Drug price trends for HALOPERIDOL DECANOATE
What excipients (inactive ingredients) are in HALOPERIDOL DECANOATE?	HALOPERIDOL DECANOATE excipients list
DailyMed Link:	HALOPERIDOL DECANOATE at DailyMed